NO20040857L - Ny oral forlenget frigivelses doseringsform. - Google Patents

Ny oral forlenget frigivelses doseringsform.

Info

Publication number
NO20040857L
NO20040857L NO20040857A NO20040857A NO20040857L NO 20040857 L NO20040857 L NO 20040857L NO 20040857 A NO20040857 A NO 20040857A NO 20040857 A NO20040857 A NO 20040857A NO 20040857 L NO20040857 L NO 20040857L
Authority
NO
Norway
Prior art keywords
dosage form
release dosage
prolonged release
new oral
oral prolonged
Prior art date
Application number
NO20040857A
Other languages
English (en)
Norwegian (no)
Inventor
Karin Ellstrom
Ulf Kjellberg
Hakan Nyquist
Anders Ringberg
Annika Schweighofer
Original Assignee
Astrazeneca Ab Global Ip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab Global Ip filed Critical Astrazeneca Ab Global Ip
Publication of NO20040857L publication Critical patent/NO20040857L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
NO20040857A 2001-08-29 2004-02-26 Ny oral forlenget frigivelses doseringsform. NO20040857L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102887A SE0102887D0 (sv) 2001-08-29 2001-08-29 New formulation
PCT/SE2002/001541 WO2003017983A1 (fr) 2001-08-29 2002-08-28 Nouvelle forme posologique orale a liberation prolongee

Publications (1)

Publication Number Publication Date
NO20040857L true NO20040857L (no) 2004-04-19

Family

ID=20285178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040857A NO20040857L (no) 2001-08-29 2004-02-26 Ny oral forlenget frigivelses doseringsform.

Country Status (14)

Country Link
US (1) US20040197404A1 (fr)
EP (1) EP1423099A1 (fr)
JP (1) JP2005504052A (fr)
KR (1) KR20040032977A (fr)
CN (1) CN1549705A (fr)
BR (1) BR0212167A (fr)
CA (1) CA2457341A1 (fr)
HU (1) HUP0401599A3 (fr)
IL (1) IL160371A0 (fr)
MX (1) MXPA04001805A (fr)
NO (1) NO20040857L (fr)
SE (1) SE0102887D0 (fr)
WO (1) WO2003017983A1 (fr)
ZA (1) ZA200401547B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1904067B2 (fr) * 2004-12-03 2017-10-11 Merck Sharp & Dohme Corp. Formulation pharmaceutique de derives de carboxamide , inhibiteurs de l'hiv integrase, comprenant une composition a liberation contrôlee
EP1946780B1 (fr) 2005-11-11 2012-01-11 Asahi Kasei Chemicals Corporation Preparation solide a liberation controlee
GB0616794D0 (en) * 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
GB0618879D0 (en) * 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
US20100069390A1 (en) 2008-09-05 2010-03-18 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (ADHD)
AU2012336036A1 (en) * 2011-11-07 2014-06-19 Diakron Pharmaceuticals Inc. An extended release formulation of a direct thrombin inhibitor
US9358204B2 (en) * 2012-02-08 2016-06-07 Supernus Pharmaceuticals, Inc. Formulations of viloxazine
EP2822542A1 (fr) * 2012-03-07 2015-01-14 Santarus, Inc. Formes posologiques solides à libération contrôlée de mésalamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4837032A (en) * 1986-02-04 1989-06-06 Farval Ag Theophylline sustained release tablet
GB8624213D0 (en) * 1986-10-09 1986-11-12 Sandoz Canada Inc Sustained release pharmaceutical compositions
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt
AR035642A1 (es) * 2000-05-26 2004-06-23 Pharmacia Corp Uso de una composicion de celecoxib para el alivio rapido del dolor

Also Published As

Publication number Publication date
MXPA04001805A (es) 2004-07-08
ZA200401547B (en) 2004-11-17
HUP0401599A2 (hu) 2004-11-29
WO2003017983A1 (fr) 2003-03-06
US20040197404A1 (en) 2004-10-07
CN1549705A (zh) 2004-11-24
HUP0401599A3 (en) 2007-03-28
EP1423099A1 (fr) 2004-06-02
SE0102887D0 (sv) 2001-08-29
KR20040032977A (ko) 2004-04-17
BR0212167A (pt) 2004-07-20
JP2005504052A (ja) 2005-02-10
CA2457341A1 (fr) 2003-03-06
IL160371A0 (en) 2004-07-25

Similar Documents

Publication Publication Date Title
TR200003788A3 (tr) Yavas salimli oral dozaj bilesim.
NO20023728D0 (no) Manipuleringsresistente, orale opioidagonistformuleringer
ZA200207755B (en) Simethicone solid oral dosage form.
EE200000497A (et) Kiiresti lahustuv peroraalne ravimvorm
NO20025450L (no) Ny farmasöytisk sammensetning
NO20030713D0 (no) Oral faststoffdose vaksine
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
NL1017075A1 (nl) Preparaat.
ITTO20000779A0 (it) Composizioni farmaceutiche.
DK1199054T3 (da) Væskefrakturhånddel
NO20033556L (no) Farmasöytiske formuleringer
ATE289796T1 (de) Orale zusammensetzung
NL1018939A1 (nl) Maandverband.
DK1381367T3 (da) Oral aripiprazolopløsning
NO20040125L (no) Enterale formuleringer
EE200300416A (et) Ravimvorm
MXPA03001425A (es) Compuestos farmaceuticos.
DE60214455D1 (de) Dentale Reibahle
DE10196204T1 (de) Orale Vorrichtungen
DE50209245D1 (de) Neuroprotektives medikament
DE60326998D1 (de) Orale zubereitung
NO20040857L (no) Ny oral forlenget frigivelses doseringsform.
NO20040966D0 (no) Orale vaksiner.
MXPA03001857A (es) Composicones medicinales.
NO20040866L (no) Ny oral forlenget frigivelses doseringsform

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application